Objectives: Current guidelines recommend biometry to identify the fetus at risk, but most small fetuses have normal outcome. We evaluated the added value of growth velocity and Dopplers in identifying term SGA fetuses with adverse perinatal outcome or neonatal morbidity. Methods: A cohort study of 22,540 pregnancies undergoing ultrasound at 20-24 weeks and at >36 weeks and delivering at term. Severe adverse perinatal outcome included stillbirth, neonatal death, hypoxic ischemic encephalopathy, inotrope use, mechanical ventilation, or severe metabolic acidosis (cord pH<7.0 & BE>12mmol/L); neonatal morbidity was defined as metabolic acidosis (cord pH<7.1 & BE>10mmol/L), or 5 min Apgar score <7, or neonatal unit admission <48 h after birth and discharge ≥8 h after admission. Regression analysis was adjusted for potential confounders, and ROC curve analysis used to assess predictive value. Results: In fetuses with EFW <10 th centile, the incidence of adverse outcomes was 5% in those with the lowest abdominal circumference (AC) velocity decile compared to 1% in those in the higher deciles; 6% in those with UA PI>1.5MoM and 2% in those below; and 4% in those with cerebroplacental ratio (CPR)<0.65MoM compared to 2% in those in the higher deciles. EFW<10 th centile was significantly associated with adverse outcomes (OR 6.38, 95% CI 4.13-9.55). Fetuses with EFW<10 th centile and the lowest AC velocity decile were at significantly higher risk (OR 11.47, compared to those without (OR 2.32; 95%CI 1.02-5.31). Those with EFW<10 th centile and UA PI>1.5MoM were at significantly higher risk (OR 11.54;) of adverse outcomes compared to those below (OR 5.66;). Those with EFW<10 th centile and CPR <0.65MoM were at significantly higher risk (OR 8.64;) of adverse outcomes compared to those above (OR 4.37;. Conclusions: Fetal growth velocity and Dopplers add value to biometry in identifying SGA fetuses with adverse outcomes at term.
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A multicentre trial on the performance of a two-step triage protocol based on initial serum progesterone and serial hCG used to manage pregnancies of unknown location (PUL) Objectives: The management of PUL often lacks uniformity and a clear evidence-base. We previously published a two-step triage protocol based on the presenting serum progesterone (step 1) and M6 model, a logistic regression model based on the initial hCG and hCG ratio two days later (step 2) to select PUL at high-risk of ectopic pregnancy (EP). This study assessed this protocols' performance and complications when used in clinical practice. Methods: A multicentre prospective cohort study was performed on 3272 consecutive PUL across eight UK hospitals. Patients had a progesterone and hCG level at 0 hours and repeat hCG at 48 hours. In seven centres, if the progesterone was ≤2nmol/l, patients were discharged with a follow-up urine pregnancy test in two weeks to confirm a negative result. If the progesterone was >2, a 48 hour hCG level was taken and results entered into the M6 model. Patients were managed according to their predicted outcome: low-risk failed PUL underwent a urine pregnancy test in two weeks and low-risk intrauterine pregnancies (IUP) a scan in one week. High-risk PUL were reviewed clinically within 48 hours. One centre used a progesterone cut-off ≤10 and was analysed separately. Results: 2623 PUL had complete outcome data. Progesterone results were available for 2333 PUL.
Step 1 (progesterone cut-off) classified 17.4% (406/2333) PUL as low-risk, of which 6 were EP (1.5% of 406). 1942 PUL had a risk classification based on the M6 model (step 2).
Step 2 classified 53.5% (1039/1942) PUL as low-risk and was correct in 99.2% (1031/1039) cases. M6 correctly classified 97.2% (278/286) EP correctly. No misclassified patients had a ruptured ectopic pregnancy or came to harm. Conclusions: The introduction of this 2-step triage effectively reduced follow-up of 70.9% PUL after just two visits. There were few misclassifications and these came to no harm. This protocol is an effective strategy for rationalising the care of women with a PUL. 
